Stockreport

NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition

NeuroSense Therapeutics Ltd. - Ordinary Shares  (NRSN) 
PDF Strengthens Global IP Portfolio for PrimeC Through 2042CAMBRIDGE, Mass., Feb. 9, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late- [Read more]